24 studies found for: Open Studies | "Wegener Granulomatosis"
Alemtuzumab for ANCA Associated Refractory Vasculitis
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
Belimumab in Remission of VASculitis
Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
† Indicates status has not been verified in more than two years